(q-value)	adjusted p-value
(CESC)	cervical squamous cell carcinoma
(CR)	complete response
(C-index)	concordance index
(CI)	confidence interval
(C1/2/3)	cluster 1/2/3
(DCA)	decision curve analysis
(EMT)	epithelial–mesenchymal transition
(ESTIMATE)	Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data
(FIGO)	Fédération Internationale de Gynécologie et d’Obstétrique
(HR)	hazard ratio
(HRG)	high-risk group
(IC-score)	immune cell score
(ICGC)	International Cancer Genome Consortium
(KM)	Kaplan–Meier
(LRG)	low-risk group
(MCP)	Microenvironment Cell Populations
(NEO)	neoantigen
(NMF)	non-negative matrix factorization
(NES)	normalized enrichment score
(OC)	ovarian cancer
(OS)	overall survival
(PR)	partial response
(PD-L1)	programmed death ligand 1
(PFS)	progression-free survival
(PD)	progressive disease
(ROC)	receiver operating characteristic
(rss)	residual sum of squares
(RMS)	restricted mean survival
(RS)	risk score
(SOC)	serous ovarian cancer
(SD)	stable disease
(TCGA)	The Cancer Genome Atlas
(TME)	tumor microenvironment
(TMB)	tumor mutation burden